- Home
- Products
Ixazomib Citrate
Ixazomib Citrate
- Generic Name: Ixazomib Citrate
- Dosage Form & Strength: Capsules – 2.3 mg, 3 mg, and 4 mg
Ixazomib Citrate is a proteasome inhibitor used in combination with lenalidomide and dexamethasone for the treatment of multiple myeloma in patients who have undergone at least one prior line of therapy.
Mechanism of Action:
Ixazomib inhibits proteasomes—complexes that break down damaged or misfolded proteins in cells. By disrupting this process in cancer cells, the drug interferes with the cell’s life cycle and slows disease progression.
FDA Approval:
The U.S. FDA approved Ixazomib in September 2015 for use in combination with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma.
Dosage & Form:
Ixazomib is available in capsule form in three strengths: 2.3 mg, 3 mg, and 4 mg. The recommended dosage and regimen must be individualized and guided by an oncologist based on patient response and tolerability.
About Multiple Myeloma:
Multiple myeloma is a cancer of plasma cells that leads to the production of abnormal proteins. Common symptoms include:
- Bone pain
- Weakness or fatigue
- Frequent infections
- Weight loss
- Excessive thirst
- Numbness or tingling in legs
- Constipation
- Confusion
Other Multiple Myeloma Medications Include: - Lenalidomide (Revlimid)
- Dexamethasone (Baycadron)
- Bortezomib (Velcade)
- Carfilzomib (Kyprolis)
- Daratumumab (Darzalex)
- Elotuzumab (Empliciti)
- Panobinostat (Farydak)
- Thalidomide, Pomalidomide, Cyclophosphamide, and others
Blood Count Suppression: Monitor for thrombocytopenia and neutropenia.
Gastrointestinal Toxicity: May cause nausea, vomiting, or diarrhea.
Peripheral Neuropathy: Report symptoms like tingling or numbness immediately.
Liver Toxicity: Monitor liver enzymes regularly during treatment.
Rash and Cutaneous Reactions: May occur; notify your healthcare provider of any skin changes.
Embryo-Fetal Risk: May cause fetal harm. Use effective contraception during and after treatment as advised.
Severe Reactions: Seek immediate help for signs of hepatotoxicity, severe rash, eye disorders, or neurological symptoms.
To Import Ixazomib Citrate into India, the following documents are required:
- A valid prescription from a qualified oncologist
- Patient’s diagnostic reports
- Government-issued patient ID proof
Order Confirmation:
Orders are processed only after receiving all required documents and, if applicable, an import permit.
Availability in India:
Ixazomib Citrate is not commonly available in local pharmacies in India. GlobalRareMeds enables access under the Named Patient Import Program, ensuring legal compliance and proper handling.
GlobalRareMeds sources Ixazomib Citrate from certified international suppliers across the USA, Europe, Canada, and Australia.
Fulfillment is handled through our Ambernath, Thane District-based logistics hub. Verified prescriptions are dispatched to patients across Indian cities including Mumbai, Delhi, Bengaluru, Hyderabad, Chennai, Pune, and more.
Contact us for pricing, documentation support, or delivery assistance:
📧 info@globalraremeds.com
📞 +91-99675 15602
📱 WhatsApp: +91-99675 15602
What is Ixazomib Citrate used for?
Ixazomib Citrate is used with lenalidomide and dexamethasone for treating multiple myeloma in patients who have undergone prior therapies.
What forms is Ixazomib available in?
It is available as capsules in 2.3 mg, 3 mg, and 4 mg strengths.
Is Ixazomib FDA approved?
Yes, it was approved in September 2015 for use in relapsed/refractory multiple myeloma.
What are the side effects of Ixazomib?
Common side effects include diarrhea, constipation, nausea, thrombocytopenia, peripheral neuropathy, and fatigue. Serious adverse events include gastrointestinal toxicity, liver damage, and embryo-fetal risk.
How can I buy Ixazomib Citrate in India?
With a valid prescription, Ixazomib can be legally imported through GlobalRareMeds under the Named Patient Program.
How should Ixazomib be stored?
Store at room temperature (20°C–25°C) away from direct heat or moisture.
Can Ixazomib be delivered to other countries?
Yes. GlobalRareMeds facilitates compliant access in India and eligible international regions based on regulatory approvals.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
